Skip to content

PolitiKit

Lobbying by AbCellera Biologics Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Corporation

AbCellera Biologics Inc.

Meetings this Parliament
71
With MPs
4
Since Nov 2021
162
Active registrations
1

Most recent reported meeting: Sep 29, 2026.

Registrations in effect

In-house (corporation) In effect since Jun 9, 2026 Receives government funding

Filed by Carl Hansen, President

Lobbyists

  • Andrew Booth · Chief Financial Officer
  • Murray McCutcheon · VP Corporate Development

Institutions they may lobby: Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC)

What they're lobbying on (1)
  • Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.

Registration 945748-366216-21. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Carl Hansen · In-house (corporation)

    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Eric Sabourin · Senior Investment Analyst, Innovation, Science and Economic Development Canada (ISED)
    • Alhadji Mamat · Manager Investment Operations, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Paul Payette · Director Business Development, National Research Council (NRC)
    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Kelley Parato · Director R&D, National Research Council (NRC)
    • Michael McCluskie · Director R&D, National Research Council (NRC)
    • Paul Payette · Director Business Development, National Research Council (NRC)
    • Rhonda Kuo Lee · Executive Advisor to the Vice President, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rhonda Kuo Lee · Executive Advisor the Vice-President, National Research Council (NRC)
    • Paul Payette · Director, Business Development, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Stacey Nunes · Business Development Officer, National Research Council (NRC)
    • Carlos Merino Hernandez · Business Development, National Research Council (NRC)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Genevieve Tanguay · Vice-Chief Science Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Lori Engler-Todd · Senior Policy Advisor Health Canada, Health Canada (HC)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
    • Jocelyn Milburn · Director, Innovation, Science and Economic Development Canada (ISED)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Melissa Sutherland · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    • Eric Costen · Associate Deputy Minister, Health Canada (HC)
    • Celia Lourenco · Acting Associate Assistant Deputy Minister, Health Canada (HC)
    and 2 more
    • Donald Sheppard · Executive Scientific Director, Health Canada (HC)
    • Greg Orencsak · Deputy Minister, Health Canada (HC)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Lakshmi Krishnan · Vice-President Research, Life Sciences (NRC), National Research Council (NRC)
    • Rhonda Kuo Lee · Executive Advisor to Vice-President, National Research Council (NRC)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Denis Martel · Director General, Innovation, Science and Economic Development Canada (ISED)
    • Adam Soloway · Manager, Innovation, Science and Economic Development Canada (ISED)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Minh-Luan Tran · Validation Lead, National Research Council (NRC)
    • Rhonda Kuo Lee · Executive Advisor to Vice President, National Research Council (NRC)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • Susan Twine · Director General, National Research Council (NRC)

    Science and Technology

    Official report

  • Reported by Carl Hansen · In-house (corporation)

    • François-Philippe Champagne · Minister of Innovation, Sciences and Economic Development, Innovation, Science and Economic Development Canada (ISED)

    Science and Technology

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.